Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract

Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The Internatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Evidence-based complementary and alternative medicine 2015-01, Vol.2015 (2015), p.1-10
Hauptverfasser: Gyan, Ben A., Arhin, Peter, Edoh, Dominic A., Bamfo-Quaicoe, Kwabena, Adjei, Samuel, Musah, Iddi, Anang, Yvonne, Appiah, Alfred A., Ngala, Robert A., Afriyie, Daniel, Asare, George Awuku, Sule, Derick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue 2015
container_start_page 1
container_title Evidence-based complementary and alternative medicine
container_volume 2015
creator Gyan, Ben A.
Arhin, Peter
Edoh, Dominic A.
Bamfo-Quaicoe, Kwabena
Adjei, Samuel
Musah, Iddi
Anang, Yvonne
Appiah, Alfred A.
Ngala, Robert A.
Afriyie, Daniel
Asare, George Awuku
Sule, Derick
description Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The International Prostate Symptom Score (IPSS), and the International Index of Erectile Function (IIEF) questionnaires were used. Total/free PSA (tPSA, fPSA), renal, liver function, lipid tests, and ultrasonographic imaging were performed. Thirty (30) patients (66 ± 11 years) completed the study. IPSS results showed 37% had severe, 40% moderate, and 23% mild symptoms before; 57% and 43% had moderate and mild symptoms, respectively, after treatment. IIED of patients’ results showed 30% with severe, 40% moderate, 24% mild-moderate, 3% mild, and 3% no erectile dysfunction before treatment and 20% severe, 43% moderate, and 37% mild-moderate dysfunction, after treatment. Quality of life (QoL) improved ( P = 0.001 ) . Significant but non-pathological increases in total and indirect bilirubin as well as apolipoprotein A occurred. Mean tPSA reduced from 27.9 ± 19.0 to 16.2 ± 11.8 ng/mL ( P = 0.002 ) ; fPSA from 6.1 ± 4.8 to 3.9 ± 2.9 ng/mL ( P = 0.045 ) ; and prostate volume from 101.8 ± 41.3 to 54.5 ± 24.8 cm3 ( P = 0.023 ) . C. membranaceus shrinks the prostate and improves QoL.
doi_str_mv 10.1155/2015/365205
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4461762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A604313859</galeid><sourcerecordid>A604313859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-fe88b5132dde8311adcf368d8771273de7312ef50459f95087da5d1f3a6df10c3</originalsourceid><addsrcrecordid>eNqN0stv0zAcB_AIgdgYnLgjS1wQqMxvJxyQRlXYpCLKS-JmubHdeCR2sZ2NXfjbcdRRBgfEya9Pvn7kV1UPEXyOEGPHGCJ2TDjDkN2qDpGgaEZxXd_e98WXg-peSucQ4kYIcbc6wBxBTgk9rH587KLzX9XGgGDBKoaUVTZAeQ3Ohm0MF0aD96PqXb6awNJZ8wK8Vb58MBifp7lXq1OwUtmVYQKXLndgHkMOHgxmWMdCWzMmsMid8qF3LfgQQgaL7zmqNt-v7ljVJ_Pguj2qPr9efJqfzpbv3pzNT5azlmGSZ9bU9ZohgrU2NUFI6dYSXutaCIQF0UYQhI1lkLLGNgzWQiumkSWKa4tgS46ql7vc7bgejG7LWaPq5Ta6QcUrGZSTf65418lNuJCUciQ4LgFPrgNi-DaalOXgUmv6XnkTxiQRbxBuiICi0Md_0fMwRl-uJ5GADW4QqfFvtVG9kc7bMD3IFCpPOKSkINb8U1FWc8oonXZ8tlNt-X8pGru_GIJyqhE51Yjc1UjRj26-xd7-KooCnu5A57xWl-7_0kwhxqobmCNawE81r8wG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1709291382</pqid></control><display><type>article</type><title>Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Gyan, Ben A. ; Arhin, Peter ; Edoh, Dominic A. ; Bamfo-Quaicoe, Kwabena ; Adjei, Samuel ; Musah, Iddi ; Anang, Yvonne ; Appiah, Alfred A. ; Ngala, Robert A. ; Afriyie, Daniel ; Asare, George Awuku ; Sule, Derick</creator><contributor>Morgia, Giuseppe ; Menachem Oberbaum</contributor><creatorcontrib>Gyan, Ben A. ; Arhin, Peter ; Edoh, Dominic A. ; Bamfo-Quaicoe, Kwabena ; Adjei, Samuel ; Musah, Iddi ; Anang, Yvonne ; Appiah, Alfred A. ; Ngala, Robert A. ; Afriyie, Daniel ; Asare, George Awuku ; Sule, Derick ; Morgia, Giuseppe ; Menachem Oberbaum</creatorcontrib><description>Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The International Prostate Symptom Score (IPSS), and the International Index of Erectile Function (IIEF) questionnaires were used. Total/free PSA (tPSA, fPSA), renal, liver function, lipid tests, and ultrasonographic imaging were performed. Thirty (30) patients (66 ± 11 years) completed the study. IPSS results showed 37% had severe, 40% moderate, and 23% mild symptoms before; 57% and 43% had moderate and mild symptoms, respectively, after treatment. IIED of patients’ results showed 30% with severe, 40% moderate, 24% mild-moderate, 3% mild, and 3% no erectile dysfunction before treatment and 20% severe, 43% moderate, and 37% mild-moderate dysfunction, after treatment. Quality of life (QoL) improved ( P = 0.001 ) . Significant but non-pathological increases in total and indirect bilirubin as well as apolipoprotein A occurred. Mean tPSA reduced from 27.9 ± 19.0 to 16.2 ± 11.8 ng/mL ( P = 0.002 ) ; fPSA from 6.1 ± 4.8 to 3.9 ± 2.9 ng/mL ( P = 0.045 ) ; and prostate volume from 101.8 ± 41.3 to 54.5 ± 24.8 cm3 ( P = 0.023 ) . C. membranaceus shrinks the prostate and improves QoL.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2015/365205</identifier><identifier>PMID: 26106434</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Alternative medicine ; Androgens ; Bilirubin ; Erectile dysfunction ; Herbal medicine ; Impotence ; Prostate ; Quality of life ; Sexual disorders</subject><ispartof>Evidence-based complementary and alternative medicine, 2015-01, Vol.2015 (2015), p.1-10</ispartof><rights>Copyright © 2015 George Awuku Asare et al.</rights><rights>COPYRIGHT 2015 John Wiley &amp; Sons, Inc.</rights><rights>COPYRIGHT 2018 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2015 George Awuku Asare et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2015 George Awuku Asare et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-fe88b5132dde8311adcf368d8771273de7312ef50459f95087da5d1f3a6df10c3</citedby><cites>FETCH-LOGICAL-c523t-fe88b5132dde8311adcf368d8771273de7312ef50459f95087da5d1f3a6df10c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461762/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461762/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26106434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Morgia, Giuseppe</contributor><contributor>Menachem Oberbaum</contributor><creatorcontrib>Gyan, Ben A.</creatorcontrib><creatorcontrib>Arhin, Peter</creatorcontrib><creatorcontrib>Edoh, Dominic A.</creatorcontrib><creatorcontrib>Bamfo-Quaicoe, Kwabena</creatorcontrib><creatorcontrib>Adjei, Samuel</creatorcontrib><creatorcontrib>Musah, Iddi</creatorcontrib><creatorcontrib>Anang, Yvonne</creatorcontrib><creatorcontrib>Appiah, Alfred A.</creatorcontrib><creatorcontrib>Ngala, Robert A.</creatorcontrib><creatorcontrib>Afriyie, Daniel</creatorcontrib><creatorcontrib>Asare, George Awuku</creatorcontrib><creatorcontrib>Sule, Derick</creatorcontrib><title>Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The International Prostate Symptom Score (IPSS), and the International Index of Erectile Function (IIEF) questionnaires were used. Total/free PSA (tPSA, fPSA), renal, liver function, lipid tests, and ultrasonographic imaging were performed. Thirty (30) patients (66 ± 11 years) completed the study. IPSS results showed 37% had severe, 40% moderate, and 23% mild symptoms before; 57% and 43% had moderate and mild symptoms, respectively, after treatment. IIED of patients’ results showed 30% with severe, 40% moderate, 24% mild-moderate, 3% mild, and 3% no erectile dysfunction before treatment and 20% severe, 43% moderate, and 37% mild-moderate dysfunction, after treatment. Quality of life (QoL) improved ( P = 0.001 ) . Significant but non-pathological increases in total and indirect bilirubin as well as apolipoprotein A occurred. Mean tPSA reduced from 27.9 ± 19.0 to 16.2 ± 11.8 ng/mL ( P = 0.002 ) ; fPSA from 6.1 ± 4.8 to 3.9 ± 2.9 ng/mL ( P = 0.045 ) ; and prostate volume from 101.8 ± 41.3 to 54.5 ± 24.8 cm3 ( P = 0.023 ) . C. membranaceus shrinks the prostate and improves QoL.</description><subject>Alternative medicine</subject><subject>Androgens</subject><subject>Bilirubin</subject><subject>Erectile dysfunction</subject><subject>Herbal medicine</subject><subject>Impotence</subject><subject>Prostate</subject><subject>Quality of life</subject><subject>Sexual disorders</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0stv0zAcB_AIgdgYnLgjS1wQqMxvJxyQRlXYpCLKS-JmubHdeCR2sZ2NXfjbcdRRBgfEya9Pvn7kV1UPEXyOEGPHGCJ2TDjDkN2qDpGgaEZxXd_e98WXg-peSucQ4kYIcbc6wBxBTgk9rH587KLzX9XGgGDBKoaUVTZAeQ3Ohm0MF0aD96PqXb6awNJZ8wK8Vb58MBifp7lXq1OwUtmVYQKXLndgHkMOHgxmWMdCWzMmsMid8qF3LfgQQgaL7zmqNt-v7ljVJ_Pguj2qPr9efJqfzpbv3pzNT5azlmGSZ9bU9ZohgrU2NUFI6dYSXutaCIQF0UYQhI1lkLLGNgzWQiumkSWKa4tgS46ql7vc7bgejG7LWaPq5Ta6QcUrGZSTf65418lNuJCUciQ4LgFPrgNi-DaalOXgUmv6XnkTxiQRbxBuiICi0Md_0fMwRl-uJ5GADW4QqfFvtVG9kc7bMD3IFCpPOKSkINb8U1FWc8oonXZ8tlNt-X8pGru_GIJyqhE51Yjc1UjRj26-xd7-KooCnu5A57xWl-7_0kwhxqobmCNawE81r8wG</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Gyan, Ben A.</creator><creator>Arhin, Peter</creator><creator>Edoh, Dominic A.</creator><creator>Bamfo-Quaicoe, Kwabena</creator><creator>Adjei, Samuel</creator><creator>Musah, Iddi</creator><creator>Anang, Yvonne</creator><creator>Appiah, Alfred A.</creator><creator>Ngala, Robert A.</creator><creator>Afriyie, Daniel</creator><creator>Asare, George Awuku</creator><creator>Sule, Derick</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract</title><author>Gyan, Ben A. ; Arhin, Peter ; Edoh, Dominic A. ; Bamfo-Quaicoe, Kwabena ; Adjei, Samuel ; Musah, Iddi ; Anang, Yvonne ; Appiah, Alfred A. ; Ngala, Robert A. ; Afriyie, Daniel ; Asare, George Awuku ; Sule, Derick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-fe88b5132dde8311adcf368d8771273de7312ef50459f95087da5d1f3a6df10c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Alternative medicine</topic><topic>Androgens</topic><topic>Bilirubin</topic><topic>Erectile dysfunction</topic><topic>Herbal medicine</topic><topic>Impotence</topic><topic>Prostate</topic><topic>Quality of life</topic><topic>Sexual disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gyan, Ben A.</creatorcontrib><creatorcontrib>Arhin, Peter</creatorcontrib><creatorcontrib>Edoh, Dominic A.</creatorcontrib><creatorcontrib>Bamfo-Quaicoe, Kwabena</creatorcontrib><creatorcontrib>Adjei, Samuel</creatorcontrib><creatorcontrib>Musah, Iddi</creatorcontrib><creatorcontrib>Anang, Yvonne</creatorcontrib><creatorcontrib>Appiah, Alfred A.</creatorcontrib><creatorcontrib>Ngala, Robert A.</creatorcontrib><creatorcontrib>Afriyie, Daniel</creatorcontrib><creatorcontrib>Asare, George Awuku</creatorcontrib><creatorcontrib>Sule, Derick</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gyan, Ben A.</au><au>Arhin, Peter</au><au>Edoh, Dominic A.</au><au>Bamfo-Quaicoe, Kwabena</au><au>Adjei, Samuel</au><au>Musah, Iddi</au><au>Anang, Yvonne</au><au>Appiah, Alfred A.</au><au>Ngala, Robert A.</au><au>Afriyie, Daniel</au><au>Asare, George Awuku</au><au>Sule, Derick</au><au>Morgia, Giuseppe</au><au>Menachem Oberbaum</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>2015</volume><issue>2015</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The International Prostate Symptom Score (IPSS), and the International Index of Erectile Function (IIEF) questionnaires were used. Total/free PSA (tPSA, fPSA), renal, liver function, lipid tests, and ultrasonographic imaging were performed. Thirty (30) patients (66 ± 11 years) completed the study. IPSS results showed 37% had severe, 40% moderate, and 23% mild symptoms before; 57% and 43% had moderate and mild symptoms, respectively, after treatment. IIED of patients’ results showed 30% with severe, 40% moderate, 24% mild-moderate, 3% mild, and 3% no erectile dysfunction before treatment and 20% severe, 43% moderate, and 37% mild-moderate dysfunction, after treatment. Quality of life (QoL) improved ( P = 0.001 ) . Significant but non-pathological increases in total and indirect bilirubin as well as apolipoprotein A occurred. Mean tPSA reduced from 27.9 ± 19.0 to 16.2 ± 11.8 ng/mL ( P = 0.002 ) ; fPSA from 6.1 ± 4.8 to 3.9 ± 2.9 ng/mL ( P = 0.045 ) ; and prostate volume from 101.8 ± 41.3 to 54.5 ± 24.8 cm3 ( P = 0.023 ) . C. membranaceus shrinks the prostate and improves QoL.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>26106434</pmid><doi>10.1155/2015/365205</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2015-01, Vol.2015 (2015), p.1-10
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4461762
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection
subjects Alternative medicine
Androgens
Bilirubin
Erectile dysfunction
Herbal medicine
Impotence
Prostate
Quality of life
Sexual disorders
title Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A26%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Shrinkage%20of%20Prostate%20and%20Improved%20Quality%20of%20Life:%20Management%20of%20BPH%20Patients%20with%20Croton%20membranaceus%20Ethanolic%20Root%20Extract&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Gyan,%20Ben%20A.&rft.date=2015-01-01&rft.volume=2015&rft.issue=2015&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2015/365205&rft_dat=%3Cgale_pubme%3EA604313859%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1709291382&rft_id=info:pmid/26106434&rft_galeid=A604313859&rfr_iscdi=true